BeyondSpring, Inc. (BYSI) Financials
BYSI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 24.8 million | 48.3 million |
| 2023-12-31 | 32.9 million | 47.6 million |
| 2023-06-30 | 32.9 million | 47.6 million |
| 2023-03-31 | 32.9 million | 47.6 million |
BYSI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | ? | ? |
| 2023-12-31 | ? | ? |
| 2023-06-30 | ? | ? |
| 2023-03-31 | 3.7 million | 833000 |
BYSI Net Income
No data available :(
BYSI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 8.0 million | - | - |
| 2023-12-31 | 15.4 million | - | 4.0 million |
| 2023-06-30 | - | - | 4.5 million |
| 2023-03-31 | 15.4 million | - | - |
BYSI Shares Outstanding
BYSI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | - | - | - | - |
| 2023-12-31 | - | 4.6 million | 2.6 million | - |
| 2023-06-30 | - | - | - | - |
| 2023-03-31 | 2.8 million | 5.8 million | 2.8 million | - |
BYSI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | - | - |
| 2023-12-31 | 437500 | - |
| 2023-06-30 | - | - |
| 2023-03-31 | 337500 | - |
BYSI
Price: $2.68
52 week price:
Earnings Per Share: -0.54 USD
P/E Ratio: -1.90
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 157900
Ebitda: -18.6 millionMarket Capitalization: 108.5 million